{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:33:11Z","timestamp":1791070391298,"version":"4.1.0"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,4,20]],"date-time":"2002-04-20T00:00:00Z","timestamp":1019260800000},"content-version":"vor","delay-in-days":719,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,5]]},"abstract":"<jats:p>Lack of sufficient cellular activity of asparagine synthetase (AS) in blast cells compared with normal tissue is thought to be the basis of the antileukaemic effect of <jats:sc>l<\/jats:sc>\u2010asparaginase in acute lymphoblastic leukaemia (ALL). Although \n\t\t\t\t\t<jats:sc>l<\/jats:sc>\u2010asparaginase is routinely used in ALL, its role and value in the treatment of acute myelogenous leukaemia (AML) is still being discussed. To evaluate the pharmacological basis for \n\t\t\t\t\t<jats:sc>l<\/jats:sc>\u2010asparaginase treatment, we established pretreatment monitoring of the intracellular AS activity in blast cells of patients with AML and ALL. There was no general difference in AS activity between ALL and AML samples. Significantly lower AS activity, however, was found in the B\u2010lineage ALL subgroups as well as AML\u2010M5.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02015.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:24:20Z","timestamp":1047363860000},"page":"427-429","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Asparagine synthetase activity in paediatric acute leukaemias: AML\u2010M5 subtype shows lowest activity"],"prefix":"10.1111","volume":"109","author":[{"given":"A.","family":"D\u00fcbbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"W\u00fcrthwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schulze\u2010Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Winkelhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kurzknabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lanvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J. L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Creutzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199901000-00003"},{"key":"e_1_2_6_3_2","first-page":"796","volume-title":"Cancer Medicine","author":"Capizzi R.L.","year":"1993"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(69)90375-X"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000469521","article-title":"Inhibition of rat liver asparagine synthetase by Cibacron Blue F3GA","volume":"31","author":"Hongo S.","year":"1984","journal-title":"Enzyme"},{"key":"e_1_2_6_6_2","first-page":"708","article-title":"Decrease in asparagine synthetase activity during cell differentiation of mouse and human leukemia cell lines","volume":"4","author":"Hongo S.","year":"1990","journal-title":"Leukemia"},{"issue":"41","key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"C1691","DOI":"10.1152\/ajpcell.1997.272.5.C1691","article-title":"Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells","volume":"272","author":"Hutson R.G.","year":"1997","journal-title":"American Journal of Physiology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2723"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"Kaspers G.J.L. Zwaan M. Creutzig U. Ritter J. Rottier M.M.A. Pieters R. Veermann A.J.P.(1998)In vitro drug resistance in childhood acute myeloid leukemia: a preliminary analysis. In:Acute Leukemias. VII. Experimental Approaches and Novel Therapies(ed. byW.Hiddemann T.Buchner B.W\u01d2rmann J.Ritter U.Creutzig M.KeatingandW.Plunkett) pp.491495 Springer\u2010Verlag Berlin\/Heidelberg .","DOI":"10.1007\/978-3-642-71960-8_64"},{"issue":"1","key":"e_1_2_6_10_2","first-page":"86a","article-title":"Immunocytochemical analysis of asparagine synthetase protein of leukemia cells: indication for \n\t\t\t\t\t\tl\u2010asparaginase treatment","volume":"88","author":"Kitoh T.","year":"1996","journal-title":"Blood"},{"issue":"1","key":"e_1_2_6_11_2","first-page":"400a","article-title":"Asparagine synthetase protein expression in leukemia cells: application of \n\t\t\t\t\t\tl\u2010asparaginase treatment for leukemia (Abstract)","volume":"92","author":"Kitoh T.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(84)90325-7"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02015.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02015.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02015.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:30:21Z","timestamp":1698589821000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02015.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02015.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02015.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"2002-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}